Scientific Programme
Scientific Programme
Search Abstract
Session

Poster session 2: Chronic Myeloproliferative disorders
Date: Saturday, June 12 2004
Time: 17:15-18:45
Room: 


17:15-18:45 432
PERICYTE COVERAGE OF ABNORMAL VESSELS IN THE MYELOFIBROSIS BONE MARROW
M.K. Zetterberg, J. Palmblad (Stockholm, Sweden)

17:15-18:45 433
ANALYSIS OF XCIP AND TELOMERASE ACTIVITY IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
R. Mangerini, N. Pujic, D. Rapezzi, A. Gallamini, S. Casciaro, D. Mattei, G.F. Gaetani, A.M. Ferraris (Genova, Italy)

17:15-18:45 434
COMPARISON BETWEEN ANAGRELIDE AND HYDROXYUREA IN THEIR ACTIVITIES AGAINST HAEMATOPOIETIC CELL GROWTH AND DIFFERENTIATION
J.D. Erusalimsky, G. Wang, C. Skene, Y. Hong (London, United Kingdom)

17:15-18:45 435
ACUTE LEUKAEMIA/MYELODYSPLASTIC SYNDROME [AL/MDS] TRANSFORMATION RATES IN ANAGRELIDE TREATED PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA [ET] AND POLYCYTHAEMIA VERA [PV]
G.I. Fiddler, A. Lyne, M. Boogaerts (Basingstoke, United Kingdom)

17:15-18:45 436
NEUTROPHIL PRV-1 GENE EXPRESSION IN MYELOPROLIFERATIVE, MYELODYSPLASTIC AND REACTIVE BLOOD DISORDERS
J. Zhang, A. Pellagatti, L. Campbell, H. Eagleton, S. Gal, C. Fidler, J. Boultwood, J.S. Wainscoat (Oxford, United Kingdom)

17:15-18:45 437
CIRCULATING ENDOTHELIAL PROGENITOR CELLS ARE INCREASED IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA
V. Rosti, M. Massa, I. Ramajoli, R. Campanelli, A. Pecci, G. Viarengo, M Marchetti, G. Barosi (Pavia, Italy)

17:15-18:45 438
POLYCYTHEMIA AND HIGH SERUM ERYTHROPOIETIN IN YOUNG PATIENTS: OCCURRENCE OF VHL MUTATION
M.L. Randi, A. Murgia, M.C. Putti, A. Casarin (Padua, Italy)

17:15-18:45 439
UTILITY OF HUMARA PCR ASSAY IN A COHORT OF SPANISH PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA.
L. Zamora, B. Espinet, L. Florensa, C. Besses, B. Bellosillo, E. Abella, E. Puigdecanet, M. Musset, S. Woessner, S. Serrano, F. Sole (Barcelona, Spain)

17:15-18:45 440
LEUKOCYTE AND PLATELET ACTIVATION IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET) AND POLYCYTHEMIA VERA (PV)
A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, T. Barbui (Bergamo, Italy)

17:15-18:45 441
A NEW PROGNOSTIC MODEL (MPI) FOR PATIENTS WITH MYELOFIBROSIS
K. Strasser-Weippl, M. Steurer, M. Kees, F. Augustin, A. Tzankov, S. Dirnhofer, N. Zojer, H. Gisslinger, H. Ludwig (Vienna, Austria)

17:15-18:45 442
CYTOGENETIC ABNORMALITIES IN MYELOFIBROSIS DETERMINED BY FISH
K. Strasser-Weippl, M. Steurer, M. Kees, F. Augustin, A. Tzankov, S. Dirnhofer, H. Gisslinger, N. Zojer, H. Ludwig (Vienna, Austria)

17:15-18:45 443
SECOND MALIGNANCIES IN ET: A RETROSPECTIVE ANALYSIS OF 306 PATIENTS WITH PROLONGED OBSERVATION TIME FROM A SINGLE INSTITUTION
F. Rossi, P. Usardi, F. Onida, P. Faccini, R. Calori, M. Colombi, A.T. Maiolo, G. Lambertenghi-Deliliers, F. Radaelli (Milan, Italy)

17:15-18:45 444
DIFFERENCES IN GENDER AND CLINICAL-HEMATOLOGICAL FINDINGS BETWEEN THE 4Q-/CHRONIC EOSINOPHILIC LEUKEMIA AND IDIOPATHIC HYPEREOSINOPHILIC SYNDROMES
R. La Starza, R. La Starza, P. Marynen, A. Aventin, G. Specchia, A. Cuneo, L. Luciano, R. Foà, C. Nozzoli, M. Cazzola, R. Invernizzi, C. Sambani, M.F. Martelli, C. Mecucci (Perugia, Italy)